Revenue: The sum of all revenue fields included for a company's operating activities.
CASI Pharmaceuticals Inc. (CASI) had Revenue of $13.36M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$13.36M |
$-14.37M |
|
$10.13M |
|
$3.23M |
|
$26.27M |
|
$-12.91M |
|
$-1.38M |
|
$-14.30M |
|
$-14.30M |
|
$-14.30M |
|
$-14.37M |
|
$-14.37M |
|
$-14.30M |
|
$-12.91M |
|
$-12.91M |
|
15.34M |
|
15.34M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
$39.58M |
|
$7.87M |
|
$14.10M |
|
$53.67M |
|
$36.45M |
|
-- |
|
$15.37M |
|
$51.82M |
|
$1.85M |
|
$1.61M |
|
$1.85M |
|
15.49M |
|
| Cash Flow Statement Financials | |
$-29.22M |
|
$11.24M |
|
$15.43M |
|
$17.08M |
|
$13.47M |
|
$-3.62M |
|
$1.31M |
|
$-0.72M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.09 |
|
-- |
|
-- |
|
-- |
|
9.93 |
|
24.17% |
|
-96.69% |
|
-96.69% |
|
-- |
|
-107.05% |
|
-107.59% |
|
$-29.45M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
1.93 |
|
0.87 |
|
103.40 |
|
-776.34% |
|
-890.89% |
|
-26.77% |
|
-776.34% |
|
$0.12 |
|
$-1.92 |
|
$-1.91 |
|